Your patient saw CAR-T on their social media feed and wants to know if it could help them. Where do you start?

Host Sheila Behimehr, NP talks with Leila Khalili, NP, a rheumatology nurse practitioner and Director of Clinical Research Operations at Hospital for Special Surgery. They cover what CAR-T cells are, why they're called "living drugs," and how a cancer therapy found its way into rheumatology.

You'll also get the full patient journey, from screening to infusion, plus the risks nurses need to know: infection, cytokine release syndrome, and neurotoxicity.

The big takeaway: CAR-T is a journey, not a single appointment. Talk about it early.

Part one of three. Next up: what the data says so far.

Got something to say to this podcast? Send a voicemail, and you might hear yourself on the next episode!

Got something to say to this podcast? Send a voicemail, and you might hear yourself on the next episode!

These labs are as common lingo to you, but do you know why they're important? Host Sheila Behimehr, MS, APRN, AGNP-C discusses the labs you read everyday and why

Got something to say to this podcast? Send a voicemail, and you might hear yourself on the next episode!

Welcome to the Rheumatology Nurses Society Official Podcast, Rheumor Has It. Because the truth is, we needed this on our drives to work!